Land: New Zealand
Sprog: engelsk
Kilde: Medsafe (Medicines Safety Authority)
Cilazapril monohydrate 1.0425mg equivalent to 1 mg Cilazapril
Apotex NZ Ltd
Cilazapril monohydrate 1.0425 mg (equivalent to 1 mg Cilazapril)
1 mg
Film coated tablet
Active: Cilazapril monohydrate 1.0425mg equivalent to 1 mg Cilazapril Excipient: Hyprolose Hypromellose Iron oxide yellow Macrogol 8000 Maize starch Microcrystalline cellulose Purified water Sodium stearyl fumarate Titanium dioxide
Prescription
Hetero Labs Limited
APO-CILAZAPRIL is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.
Package - Contents - Shelf Life: Bottle, White HDPE opaque round bottle with blue PP cap and lift N peel Al liner, Desiccant in caniste - 200 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture
2016-05-25
NEW ZEALAND DATA SHEET APO-CILAZAPRIL 1. APO-CILAZAPRIL (1MG, 2.5MG & 5MG FILM COATED TABLETS) APO-CILAZAPRIL 1mg film coated tablets APO-CILAZAPRIL 2.5mg film coated tablets APO-CILAZAPRIL 5mg film coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Cilazapril monohydrate 1.0425mg (equivalent to Cilazapril 1mg) Cilazapril monohydrate 2.606mg (equivalent to Cilazapril 2.5mg) Cilazapril monohydrate 5.213mg (equivalent to Cilazapril 5mg) Chemical Structure: Molecular Formula: C 22 H 31 N 3 O 5 .H 2 O Molecular Mass: 435.50 Excipient(s) with known effect APO-CILAZAPRIL contains corn starch. APO-CILAZAPRIL is gluten free and lactose free For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM 1mg APO-CILAZAPRIL Yellow, oval, biconvex, film coated tablet. Engraved “CZ” over European bisect “1” on one side, “APO” on the other side. Each tablet typically weighs 82mg 2.5mg APO-CILAZAPRIL Dusty rose, oval, biconvex, film coated tablet. Engraved “CZ” over European bisect “2.5” on one side, ’APO” on the other side. Each tablet typically weighs 82mg. Please refer to Medsafe website (www.medsafe.govt.nz) for the most recent datasheet Page 1 of 14 APO-CILAZAPRIL 5mg APO-CILAZAPRIL Reddish-brown, oval, biconvex, film coated tablet. Engraved “CZ” over European bisect “5” on one side, “APO” on the other side. Each tablet typically weighs 82mg. The tablet can be divided into equal doses 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • APO-CILAZAPRIL is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. • APO-CILAZAPRIL is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics. 4.2 DOSE AND METHOD OF ADMINISTRATION DOSE STANDARD DOSAGE APO-CILAZAPRIL should be administered once daily. As food intake has no clinically significant influence on absorption, APO-CILAZAPRIL can be administered before or after a meal. The dose should always be taken at about the sa Læs hele dokumentet